The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH awards CWRU $4.4 million over 7 years.

By | October 2, 2002

As Co-Investigator of this “Renal Framingham” cohort study Ash Sehgal, MD will follow 3000 patients with chronic renal insufficiency over 7 years to determine factors associated with progression of renal failure and development of cardiovascular disease among patients with chronic renal insufficiency.

“Understanding why patients with renal insufficiency progress or develop cardiovascular disease, may help develop interventions to improve outcomes”, said Sehgal. Cleveland is one of six sites that will contribute patients to the study. MetroHealth Medical Center is one of the 5 hospitals within the city that makes up the Cleveland site.MetroHealth Medical Center